Home
Breast & breast cancer
Breast cancer Benign breast lesions Prophylactic mastectomy
Breast reconstruction
All techniques Implant reconstruction Latissimus dorsi flap DIEP flap (abdomen) Gracilis flap (thigh) Fat grafting (lipofilling) Flat closure Intimate surgery
Benign gynaecological surgery
Uterus Ovaries and tubes Cervix Vulva and vagina
Gynaecological cancers
Cervical cancer Ovarian cancer Uterine cancer Vulvar cancer Borderline tumours Articles About
Request a callback Book on Doctolib →
Dr Zeitoun, smiling, sees a patient in consultation, on either side of his desk.
Breast cancer

Local recurrence of breast cancer what to do now?

Your biopsy report mentions a local recurrence, or follow-up imaging has shown an abnormality near the scar. A local recurrence means that cancer cells have reappeared in the breast that has already been treated, or on the chest after a mastectomy. It does not mean that the disease has already spread to other organs. The work-up, followed by a discussion at a multidisciplinary team meeting, makes it possible to understand what is happening and to organise the treatment.

Dr Jérémie Zeitoun
In brief
DEFINITIONS

Local recurrence, regional recurrence or new cancer

These three situations are not treated in the same way. The work-up serves first of all to tell them apart.

Local recurrence

A local recurrence is the reappearance of cancer cells in the breast that has already been treated, most often near the scar or in the bed of the first tumour. After a mastectomy, it is located on the chest, in the skin or the scar.

It can be invasive, meaning that the cells have crossed the basement membrane of the ducts or lobules, or it can be a ductal carcinoma in situ, meaning that the cells remain inside the ducts or lobules. This distinction, made on the biopsy and then on the surgical specimen, changes the work-up and the treatment.

A local recurrence is not a metastasis. A metastasis means that cells have settled in another organ, for example a bone, the liver or the lung. An isolated local recurrence remains a disease of the breast or the chest, most often treated with the aim of cure.

Regional recurrence

A regional recurrence is often in the axillary lymph nodes, that is, located in the lymph nodes of the armpit. When the involvement is supraclavicular or infraclavicular, above or below the collarbone, or internal mammary, behind the breastbone, it is rather called a locoregional recurrence. A lump under the armpit after breast cancer is not necessarily a recurrence: a lymph node can react to an infection or a vaccine.

Only the examination, the ultrasound and, if needed, a biopsy can tell. When lymph nodes are involved, the treatment generally combines a surgical procedure, often radiotherapy of the area, and in some cases chemotherapy, sometimes combined with immunotherapy or targeted therapy.

A new cancer

Two medical files placed side by side on a consulting-room desk.

A new cancer, distinct from the first, can occur in the other breast or in the same breast. It then differs in its location and/or its characteristics: the type of cells seen under the microscope, known as the histological type, and the receptors (for oestrogen, for progesterone, or the HER2 protein). It is distinguished from a true recurrence.

A new cancer in the other breast is treated like a first cancer, with its own work-up. The distinction relies on the site, the type of cells, the markers and the time since the first treatment. In case of doubt, the guidelines reason as for a recurrence.

THE WORK-UP

The work-up: imaging, biopsy, staging work-up

The work-up has three aims: to confirm that it is indeed a recurrence, to specify its type, and to check that the disease is not present elsewhere. The imaging and the biopsy are performed by the radiologist. The surgeon then sees you, with the reports and the images.

Imaging of the breasts and armpits

The local work-up includes a mammogram and an ultrasound of both breasts, with an ultrasound of the armpits. In case of recurrence, a breast MRI is readily prescribed, or a contrast-enhanced mammogram, a mammogram with injection of a contrast agent, if it is technically feasible in the centre. A second breast-conserving treatment is rarely performed after breast cancer, but it is discussed case by case.

These examinations look at the suspicious area, the rest of the breast, the other breast and the lymph nodes. They do not replace the biopsy: an image classified ACR 4 or ACR 5 on a mammogram indicates that a sample is needed; it is not yet a diagnosis.

The biopsy

Ultrasound-guided breast biopsy: the radiologist guides the needle to the target area, the patient draped, her face calm.

A new core needle biopsy, under local anaesthetic, confirms the diagnosis. The radiologist guides it by ultrasound, by mammography or, more rarely, by MRI, depending on how the area is best seen.

The pathology report says whether the lesion is a carcinoma in situ or an invasive cancer, its grade, and the markers tested by immunohistochemistry, a staining of the cells under the microscope: oestrogen receptors, progesterone receptors, HER2 protein. These markers may be different from those of the first cancer. The old analysis is therefore not enough on its own.

The time to result depends on the laboratory. A quick result is not, in itself, a bad sign. If a lymph node looks suspicious, it is also sampled, most often under ultrasound.

The staging work-up

When the recurrence is invasive, the guidelines generally provide for a staging work-up, to look for possible involvement of other organs before deciding on the operation. The 18-FDG PET scan is the examination most often offered.

If it is not available, a CT scan of the chest, abdomen and pelvis combined with a bone scan replaces it. In case of invasive lobular carcinoma, these two strategies can be used, because the PET scan is sometimes less informative.

For a purely in situ recurrence, the PET scan is not recommended. For a very small invasive focus confined to the breast, a staging work-up is not always necessary. Tumour markers do not make the diagnosis, but they can help in case of a rise over several successive blood tests.

SURGERY

Surgery: often a mastectomy

When the staging work-up shows no distant disease, local treatment relies first on surgery.

After breast-conserving treatment and radiotherapy

The doctor talks with a patient across the desk after the operation.

If the first treatment was a lumpectomy — sometimes with oncoplastic surgery, which removes the tumour and reshapes the breast at the same time — followed by radiotherapy, the guidelines retain mastectomy as the recommended treatment of local recurrence. The breast has already received radiotherapy: a further breast-conserving operation, with no possibility of re-irradiation, is not recommended.

A second breast-conserving treatment is not the recommended treatment. It is rarely performed after breast cancer, but it is possible case by case, according to the precise indications of the guidelines, discussed at the multidisciplinary team meeting and with you. Mastectomy remains the recommended treatment.

The guidelines specify that this option can be discussed when the following conditions are all met at the same time: age over 60; a tumour expressing oestrogen and progesterone receptors, with a low Ki67, that is, a low proliferation marker, without excess HER2 protein, and without lymph node involvement, or a ductal carcinoma in situ of any grade; size of 2 cm or less; recurrence occurring more than five years after the first treatment; a unifocal lesion, that is, confined to a single focus; breast-conserving surgery feasible in good conditions, in particular for the cosmetic result and the condition of the skin after radiotherapy; information on the risks and the patient’s agreement. Partial breast irradiation is then discussed, in the absence of severe sequelae from the first radiotherapy. This option is not retained in the case of a lobular type, an invasive cancer associated with extensive ductal carcinoma in situ, or if there is a genetic predisposition to breast cancer.

The indication also takes into account the radiotherapy doses already received, the timing of the recurrence, the characteristics of the tumour and the toxicities of the first treatment. In these situations, a radiotherapy consultation takes place before the operation, to confirm the possibility of further irradiation and to assess the toxicities, in particular to the skin, of the first treatment.

If mastectomy is refused, breast-conserving surgery combined with accelerated partial breast irradiation can be an option, provided that the recurrence occurred more than five years after the first treatment.

This option carries a higher risk of a new local recurrence. It does not change overall survival. It also exposes to complications, in particular cosmetic ones, in a breast that has already been irradiated.

It is never an obligation. Mastectomy remains the recommended treatment.

When the lesion is not palpable, preoperative localisation (guide wire or magnetic clip) is organised by the radiologist the day before or the morning of the operation. The choice between keeping the breast or removing it, when it arises at the first treatment, is explained on the page lumpectomy or mastectomy. Here, the context is different: the breast has already been operated on and irradiated.

After a first mastectomy

When the recurrence is located on the chest after a mastectomy, the procedure most often consists of removing the affected area, with a margin of healthy tissue, once the staging work-up has been done. If there was a flat closure and there is a recurrence on the chest, no immediate reconstruction is done at that time, because the skin — or rather the skin envelope — has to be reconstructed.

Secondary reconstruction is done at a distance from any recurrence. What follows — radiotherapy, systemic treatment — depends on the extent of the lesion, the treatments already received and the discussion at the multidisciplinary team meeting.

The lymph nodes of the armpit

The procedure on the lymph nodes depends on what has already been done, and on the current imaging of the armpit.

If the first treatment included a sentinel lymph node procedure, the first lymph node relay for the lymph of the breast, and there are no signs of lymph node involvement, a new sentinel lymph node procedure can be offered in case of recurrence after breast-conserving treatment. After a mastectomy, no new sentinel lymph node procedure is done, because the mammary gland is no longer present. In this situation, a lymph node procedure, or even an axillary dissection, is discussed.

If an axillary dissection, the removal of several lymph nodes from the armpit, has already been done, a new procedure is not systematic. It is discussed if it would change the systemic treatment or the radiotherapy, or if a lymph node appears suspicious and the biopsy confirms it. If a lymph node is already known to be involved before the operation, the procedure is adapted at the multidisciplinary team meeting.

The aftermath of a procedure on the armpit, and the useful steps to limit swelling of the arm, are described on the page lymphoedema prevention.

Reconstruction, immediate or delayed

Reconstruction is not a treatment for the cancer, and it is not compulsory. You may wish to regain breast volume, or a flat closure. This decision can also be made later.

After breast cancer irradiated following breast-conserving treatment, if a mastectomy is performed and reconstruction is wished for, immediate reconstruction with a flap is readily offered. Reconstruction with an implant is possible, but often advised against in view of the risks and postoperative complications.

If there was a flat closure and there is a recurrence on the chest, no immediate reconstruction is done at that time, because the skin — or rather the skin envelope — has to be reconstructed. Secondary reconstruction is done at a distance from any recurrence.

The options usually discussed are reconstruction with an implant, sometimes in several stages; a latissimus dorsi flap, which uses the muscle and skin of the back; a DIEP flap, which uses the skin and fat of the abdomen, performed with a microsurgery team; a gracilis flap, taken from the inner thigh, also with a microsurgery team; lipofilling, which reinjects your own fat, most often as a complement once the tissues have stabilised; then, once the volume has been restored, nipple reconstruction and areola tattooing. After previous radiotherapy, the flap is the technique readily offered for immediate reconstruction.

Preserving the skin or the nipple-areola complex (NAC) at the time of the mastectomy is explained on the page dedicated to preserving the nipple-areola complex.

Several operations, spread over 18 to 24 months, are sometimes necessary for touch-ups. The result can be very beautiful, while remaining different from the breast before. The page breast reconstruction presents all the techniques.

Dr Zeitoun practises in Sector 2 (non-OPTAM) and charges fees above the French Social Security rate for all consultations and procedures. Most international patients are not covered by French Social Security. A detailed quote is given during the consultation, before any procedure. If you are covered, the Assurance Maladie reimburses on the basis of the Social Security rate, and your health insurance may cover all or part of the additional fees, depending on your policy.

Practical advice before the operation is on the page preparing for your operation, and advice for the first weeks on the page postoperative recovery.

PROGNOSIS

What can be said about the prognosis, without false precision

An isolated local recurrence is not, in itself, the announcement of a generalised disease. When it is confined to the breast or the chest, after a reassuring staging work-up, treatment is undertaken with the aim of cure.

Several factors weigh more than a single figure, which no one can invent for your situation: the type of the recurrence, a carcinoma in situ not having the same significance as an invasive cancer; the time since the first treatment, a recurrence occurring after several years not having the same meaning as an early recurrence; the size, the grade, lymph node involvement; the markers (hormone receptors, HER2); the absence or presence of distant lesions.

The subtype of the first cancer also matters. A recurrence of a hormone-sensitive cancer, a HER2-positive cancer or a triple-negative cancer is not discussed in the same way.

Age at the time of the recurrence, and the treatments already received, enter into the same reflection. The prognosis is discussed with you, on the basis of your file, not on the basis of a percentage read out of context.

Frequently asked questions

The questions asked most often after the announcement of a local recurrence. If yours is not here, ask it at the consultation.

Does a local recurrence mean that the cancer has spread throughout the body?

No. A local recurrence is located in the breast that has already been treated or on the chest. Distant disease, in another organ, is called a metastasis. It is the role of the staging work-up to check this distinction before deciding on the operation.

Is a mastectomy always necessary?

After breast-conserving treatment and radiotherapy, mastectomy is the recommended treatment. A second breast-conserving treatment is not the recommended treatment. It is rarely performed, but it can be discussed case by case, according to the precise indications of the guidelines, at the multidisciplinary team meeting. A radiotherapy consultation is then discussed case by case, to examine the possibility of further irradiation. It is not recommended to repeat a lumpectomy without the possibility of further irradiation.

Can the breast be reconstructed straight away, even though it has already been irradiated?

After breast cancer irradiated following breast-conserving treatment, if a mastectomy is performed and reconstruction is wished for, immediate reconstruction with a flap is readily offered. An implant is possible, but often advised against in view of the risks and postoperative complications. If there was a flat closure and there is a recurrence on the chest, no immediate reconstruction is done at that time, because the skin — or rather the skin envelope — has to be reconstructed. Secondary reconstruction is done at a distance from any recurrence. The decision is made with you, taking into account the condition of the skin, your body shape and what you wish.

Does the recurrence necessarily have the same type as the first cancer?

Not necessarily. Hormone receptors and HER2 status can change. That is why a new biopsy is essential. The pathology report of this biopsy guides the associated treatments.

How is the staging work-up done?

For an invasive recurrence, a PET scan is most often offered. If it is not available, a CT scan of the chest, abdomen and pelvis is combined with a bone scan. For a purely in situ recurrence, the PET scan is not recommended. Tumour markers do not make the diagnosis, but they can help in case of a rise over several successive blood tests.

What is the prognosis of a local recurrence?

It depends on the type (in situ or invasive), the time since the first treatment, the lymph nodes, the markers and the absence of distant lesions. An isolated local recurrence is treated with the aim of cure. No single percentage applies to all situations.

Should I have a genetic test?

If testing was not done at the time of the first cancer, it can be offered according to the guidelines: age, triple-negative form, personal or family history, involvement of both breasts. The result also concerns your relatives, if they wish to be informed and, where appropriate, tested. See the page hereditary breast and ovarian cancer risk.

Is pain near the scar a sign of recurrence?

After a lumpectomy or a mastectomy, pain related to the small nerves of the chest is common. A change in the scar, a new lump or a change in the skin should be examined, with imaging and, if needed, a biopsy. See also pain after a mastectomy.

How does surveillance work afterwards?

A clinical examination every six months for five years, then once a year, and a yearly mammogram and ultrasound of the remaining breast and of the other breast, for life. After a mastectomy, the operated side is followed by clinical examination. Report any new sign without waiting for the next visit.

Can I ask for a second opinion?

Yes, it is your right, and it does not delay treatment when it is organised quickly. Bring the biopsy report, the images, the reports of the treatments already received and, if there is one, the report of the multidisciplinary team meeting. See second opinion for breast cancer.

What are Dr Zeitoun’s fees?

Dr Zeitoun practises in Sector 2 (non-OPTAM) and charges fees above the French Social Security rate for all consultations and procedures. Most international patients are not covered by French Social Security. A detailed quote is given during the consultation, before any procedure. If you are covered, the Assurance Maladie reimburses on the basis of the Social Security rate, and your health insurance may cover all or part of the additional fees, depending on your policy.

FREN
ONLINE CONSULTATIONVideo consultation · by appointment